Stock screener
All disclosures →
EDGAR →
GMED
Conviction 21HealthcareScan · Thu, Sep 24, 2026Globus Medical Inc (GMED) closed at $74.31 (+0.47%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 38, RS Rating 78, -23.3% from its 52-week high, -14.9% year to date. Sector: Healthcare · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
GMED$74.31+0.47%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 1.72M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price74.31
Change+0.47%
Gap+0.53%
Rel volume1.61×
Avg volume1.51M
Avg $ vol114.9M
SMA 2076.67
SMA 5079.77
SMA 20085.02
Price vs 50-6.85%
Price vs 200-12.60%
MA stackbearish
50/200 cross—
Supertrenddown · 79.81
RSI (14)38
MACD hist-0.07
MACD cross—
Stoch %K / %D25 / 21
ADX (14)24
+DI / −DI17 / 27
RSI divergence—
MACD divergence—
ATR %2.69%
ADR %2.48%
52w high96.82
52w low55.10
From 52w high-23.25%
Above 52w low+34.86%
New 52w highNo
SqueezeOff
Bollinger width16.29%
%B0.31
Donchian pos13.16%
Donchian high84.01
Donchian low72.84
AVWAP (52w high)83.73
vs AVWAP high-11.25%
AVWAP (52w low)81.66
vs AVWAP low-9.00%
OBV trendFlat
Chaikin MF (20)-0.21
Today vs 20d1.61×
Avg vol (14d)1.72M
Avg vol (20d)1.51M
Avg $ vol (20d)114.9M
Market cap9.98B
RS Rating78 / 99
RS 3m (vs SPY)-16.71%
RS 6m (vs SPY)-31.75%
RS line new highNo
Trend template2/8
Technical rank24.4
1 week+0.20%
1 month-10.43%
3 months-12.22%
6 months-14.93%
1 year+30.94%
YTD-14.88%
P/E18.55
P/B2.09
P/S3.39
P/FCF16.95
EPS3.92
Div yield—
ROE11.28%
ROA9.80%
Debt/Eq—
Current4.62
EV/EBITDA12.51
Gross margin34.72%
Net margin18.30%
Rev growth16.65%
EPS growth422.28%
Price target102.55
Target upside38.00%
Analyst ratingBuy
Institutional126.45%
Ent. value9.47B
Revenue789.61M
Net income151.57M
Gross profit369.65M
Free cash flow588.77M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNYSE
Shares out—
Employees6K
ListedFri, Aug 3, 2012
Free float132.06M
Float %97.6%
Short interest6.62M
Days to cover6.5d
Short volume72.2%
Squeeze score64 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.34 vs $1.12
Last surprise+19.6% beat
Setup gradeD
Conviction21 / 100
Pattern quality—
Tech rank24.4 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance88.51
Support73.01
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GMED · 5 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Gilbert Cisneros house · D · CA · traded 2026-08-19 | Buy | $15K–$50K | 2026-08-19 | 2026-09-10 | |
 Lisa McClain house · R · MI · traded 2025-06-24 | Sell | $1K–$15K | 2025-06-24 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-07-10 | Sell | $1K–$15K | 2025-07-10 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-17 | Buy | $1K–$15K | 2025-06-17 | 2025-08-13 | |
 Josh Gottheimer house · D · NJ · traded 2025-04-09 | Sell | $1K–$15K | 2025-04-09 | 2025-05-14 |
Insider activity
SEC Form 4 transactions in GMED · open-market 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
ZARRILLI STEPHEN T Director · Class A Common Stock · 2026-08-18 | Exercise | 25K | $1.3M | 2026-08-18 | 2026-08-19 |
ZARRILLI STEPHEN T Director · Stock Option (Right to Buy Class A Common Stock) · 2026-08-18 | Exercise | 25K | — | 2026-08-18 | 2026-08-19 |
ZARRILLI STEPHEN T Director · Class A Common Stock · 2026-08-18 | Sell | 25K | $2.2M | 2026-08-18 | 2026-08-19 |
Davidar David D Director · Class A Common Stock · 2026-07-27 | Gift | 2.5K | — | 2026-07-27 | 2026-07-28 |
Davidar David D Director · Stock Option (Right to Buy Class A Common Stock) · 2026-06-05 | Exercise | 25K | $0 | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Sell | 25K | $2.0M | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-09 |
Davidar David D Director · Class A Common Stock · 2026-06-05 | Exercise | 25K | $657K | 2026-06-05 | 2026-06-09 |
RHOADS ANN D Director · Class A Common Stock · 2026-06-04 | Exercise | 25K | $657K | 2026-06-04 | 2026-06-08 |
RHOADS ANN D Director · Stock Option (Right to Buy Class A Common Stock) · 2026-06-04 | Exercise | 25K | $0 | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in GMED · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.